|
|
|
07 Mar 2007 |
Amarin Expands Neurology Pipeline With Epilepsy Product Candidate
|
|
06 Mar 2007 |
Biocryst And Shionogi Establish Collaboration In Japan
|
|
02 Mar 2007 |
KeyNeurotek AG and Grünenthal GmbH sign exclusive licensing agreement for drug development and marketing
|
|
28 Feb 2007 |
PPD Licenses Statin from Ranbaxy Laboratories
|
|
28 Feb 2007 |
Vaccinex Announces Antibody Development And Commercialization Alliance In Multiple Sclerosis And Oncology
|
|
27 Feb 2007 |
Trius Therapeutics Completes $20 Million Series A Financing and Names CEO
|
|
27 Feb 2007 |
Novelix Announces Licensing of Cancer Compound to AOP Orphan Pharmaceuticals
|
|
27 Feb 2007 |
Ipsen Grants Galderma Exclusive Rights to Develop, Promote and Distribute Its Botulinum Toxin Type A Product for Aesthetic Indications in Europe and Certain Other Territories
|
|
22 Feb 2007 |
TransTech Pharma, Inc. obtains exclusive licence to glucokinase activator programme for the treatment of diabetes from Novo Nordisk
|
|
21 Feb 2007 |
Stem Cell Sciences Licenses Neural Stem Cell Technology to Merck & Co., Inc.
|
|
21 Feb 2007 |
Roche and GSK agree on two transactions
|
|
17 Feb 2007 |
InSite Vision Announces License Agreement With Inspire Pharmaceuticals
|
|
15 Feb 2007 |
GW and Otsuka Announce Major Long Term Strategic Cannabinoid Alliance
|
|
15 Feb 2007 |
Acambis signs JE partnership agreement with sanofi pasteur
|
|
13 Feb 2007 |
Medivir Outlicenses The Antiviral Compound MIV-160 To Guangdong Lantai Viewland Pharmaceutical CO. LTD
|
|
10 Feb 2007 |
Q-Med has entered into a development and commercialisation agreement regarding botulinum toxin products
|
|
09 Feb 2007 |
SRI International and Telik Announce Exclusive License for SRI to Develop Autoimmune and Inflammatory Disease Drug Candidate
|
|
09 Feb 2007 |
GlaxoSmithKline and Fabre-Kramer Pharmaceuticals enter global agreement for new treatment of major depressive disorder
|
|
09 Feb 2007 |
GlaxoSmithKline and XenoPort announce agreement on late-stage compound for RLS and neuropathic pain
|
|
07 Feb 2007 |
ImClone Systems Opts-out of Development Agreement with UCB to Focus Resources on Proprietary, Anti-VEGFr-2 Antibody IMC-1121B
|
|
06 Feb 2007 |
AstraZeneca Licenses Regeneron's Velocimmune(R) Technology For Discovering Human Monoclonal Antibodies
|
|
06 Feb 2007 |
elbion and Wyeth Enter Collaboration to Develop New Treatments for Schizophrenia
|
|
06 Feb 2007 |
UCB Licenses BioWa's POTELLIGENT(R) Technology for use in Antibody Research and Development
|
|
03 Feb 2007 |
Schering-Plough Cites Today's Anacor Agreement as Latest in Series of Deals
|
|
02 Feb 2007 |
Galapagos announces PPAR-delta commercial license agreement with Hillcrest Therapeutics
|
|
31 Jan 2007 |
Debiopharm Signs R&D And Commercialisation Agreement With Kirin For The Development Of DEBIO-0719 In Oncology
|
|
25 Jan 2007 |
Kirin and Astellas Enter Into a Licensing Agreement on an Immunosuppressive Fully Human Monoclonal Antibody
|
|
25 Jan 2007 |
Foamix Signs R&D Collaboration And License Agreement With Dr. Reddy's Laboratories, Inc's For The Development And Commercialization Of Psoriasis Foam
|
|
23 Jan 2007 |
Shire licenses the North American rights for SPD754 (apricitabine) to Avexa Ltd
|
|
23 Jan 2007 |
Wockhardt signs in-licensing pact with Crawford Healthcare of UK, Launches Vitix for vitiligo skin disorder
|
|
20 Jan 2007 |
Bayer Schering Pharma to develop new imaging compounds for detection of Neurodegenerative Diseases
|
|
17 Jan 2007 |
Genizon Biosciences Announces a License and Collaboration Agreement with Pfizer in Three Major Diseases
|
|
17 Jan 2007 |
DOV Pharmaceutical Announces Exclusive Agreement for the Development and Commercialization of Bicifadine
|
|
13 Jan 2007 |
Nicholas Piramal announces Drug Development Agreement with Eli Lilly and Company.
|
|
13 Jan 2007 |
BioInvent enters collaboration with Genentech to develop and commercialize BioInvent's proprietary antibody for the potential treatment of cardiovascular diseases
|
|
13 Jan 2007 |
Bioxell Acquires Novel Compound from Roche
|
|
12 Jan 2007 |
Bristol-Myers Squibb and AstraZeneca Announce Worldwide Collaboration to Develop and Commercialize Diabetes Compounds
|
|
12 Jan 2007 |
Immuno-Biological Laboratories Co., Ltd. and Intellect Neurosciences, Inc. Enter into Humanized Monoclonal Antibodies Development Agreement for the Treatment of Alzheimer's Disease
|
|
11 Jan 2007 |
InteKrin Therapeutics Licenses Diabetes Product
|
|
11 Jan 2007 |
Organon and the Academic Medical Center jointly develop novel treatment of rheumatoid arthritis
|
|
10 Jan 2007 |
Alnylam and Inex Form Strategic Technology Alliance to Discover and Develop RNAi Therapeutics with Lipid-Based Delivery Formulations
|
|
09 Jan 2007 |
Cambridge Antibody Technology Licenses Monoclonal Antibody (CAT-213) For Treatment Of Allergy Disorders To iCO Therapeutics
|
|
09 Jan 2007 |
Cytochroma Inc. and aOvaTechnologies, Inc., Sign License Agreement.
|
|
06 Jan 2007 |
DSM Biologics and Crucell Announce PER.C6(R) Licensing Agreement with Biotecnol SA for Antibody Production
|
|
05 Jan 2007 |
Raven Biotechnologies, Inc. And Wyeth (WYE) Partner To Evaluate And Develop
|
|
05 Jan 2007 |
Elusys Announces Collaborative Research And License Agreement With Pfizer
|
|
05 Jan 2007 |
Roche and Synosis Therapeutics Announce Partnership to Explore Potential of Five Compounds Targeting the Central Nervous System
|
|
05 Jan 2007 |
Oscient Pharmaceuticals and Menarini Group Enter into European Commercialization Agreement for FACTIVE Tablets
|
|
05 Jan 2007 |
Sunesis Out-Licenses LFA-1 Program to SARcode Corporation
|
|
05 Jan 2007 |
BioAxone Therapeutic Licenses Phase II Spinal Cord Injury Drug Cethrin(R) to Boston Life Sciences
|
| |
|
Results 401 - 450 of 814 |
